Skip to main content
Figure 5 | Clinical Proteomics

Figure 5

From: Proteomic analysis of human plasma in chronic rheumatic mitral stenosis reveals proteins involved in the complement and coagulation cascade

Figure 5

Identification of pathways associated with Rheumatic Mitral Stenosis. Proteins marked by red circles indicate those that are found to be differentially abundant and/or common to the control and patient groups. Proteins indicated by blue circles are identified only in the patient group. A2M, α-2-macroglobulin; BF, complement factor B; C1Q, complement component 1,q subcomponent; C1S, complement component 1, s subcomponent; C3,complement component 3; C4,complement component C4; C4BP, complement component 4 binding protein; C9, complement component C9; F2,coagulation factor II or prothrombin; FG, fibrinogen; HF1,complement factor H; KNG, kininogen 1; PLG, plasminogen; PROS1,protein S α; SERPIN A1,serpin peptidase inhibitor, clade A member 1 or α-1-antitrypsin; SERPINC1,serpin peptidase inhibitor, clade C, member 1 or antithrombin III; SERPIND1,serpin peptidase inhibitor, clade D, member 1or heparin cofactor II; SERPING1,serpin peptidase inhibitor, clade G, member 1 or C1 inhibitor.

Back to article page

Clinical Proteomics

ISSN: 1559-0275